Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02321293 |
| Title | A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC |
| Acronym | CURCUMIN |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Lady Davis Institute |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | CAN |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Peter Brojge Lung Cancer Center, Jewish General Hospital | RECRUITING | Montreal | Quebec | H3T 1E2 | Canada | Details |